Arctuvan
Drugapplication of a herbal drug in the clinical trial REGATTA (NCT03151603)
NCT Number: NCT03176563
Observational follow-up study of patients included in the clinical trial REGATTA.
Looking for future studies?
Notify Me18 year–75 year
Female
Observational
Hausarztpraxis Dr. Raby, Achim, Germany
A follow-up telephone interview of the participants of the clinical trial REGATTA exploring the occurrence of urinary tract infections, pyelonephritis within a follow-up period of three months after inclusion.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
application of a herbal drug in the clinical trial REGATTA (NCT03151603)
application of Placebo to Fosfomycin in the clinical trial REGATTA (NCT03151603)
application of an antibiotic drug in the clinical trial REGATTA (NCT03151603)
application of Placebo to Arctuvan in the clinical trial REGATTA (NCT03151603)
Time frame: 3 months after inclusion in REGATTA
number of urinary tract infection within 3 months after inclusion in REGATTA
Time frame: 3 months after inclusion in REGATTA
number of pyelonephritis within 3 months after inclusion in REGATTA
University Medical Center Goettingen
Other
Observational Study of Patients With Uncomplicated Urinary Tract Infection Treated With Antibiotics or Herbal Medicinal Product
Acronym: REGATTA II
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07627412
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Nanjing, Jiangsu, China
View Trial DetailsNCT06801405
Acute Kidney Injury, Antibiotic Prophylaxis
Jales, São Paulo, Brazil
View Trial DetailsNCT05319561
Common Infections, Female Urogenital Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT07438184
Chronic Prostatitis (CP), Female Urogenital Diseases
Salamanca, Spain
View Trial Details